ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Update

ViaDerma, Inc. (OTCMKTS:VDRM) was the target of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 12,400 shares, a decline of 86.1% from the February 13th total of 89,100 shares. Based on an average trading volume of 2,825,700 shares, the short-interest ratio is currently 0.0 days.

ViaDerma Price Performance

OTCMKTS:VDRM traded up $0.00 during trading hours on Friday, hitting $0.02. 4,325,926 shares of the company’s stock traded hands, compared to its average volume of 2,599,919. ViaDerma has a 52 week low of $0.00 and a 52 week high of $0.02. The business’s fifty day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01.

About ViaDerma

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.